Huaxing Ma

机构：Guiyang Medical University, Affiliated Hospital of Guizhou Medical University

发表论文 12 篇 · 总被引 115 次 · h-index 6

代表论文

• Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis (2023 · BMC Cancer · 被引 27)
• Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance (2015 · Tumor Biology · 被引 22)
• Inflammatory Cell–Derived MYDGF Attenuates Endothelial LDL Transcytosis to Protect Against Atherogenesis (2023 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 20)
• Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance (2017 · Tumor Biology · 被引 15)
• TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway (2023 · Biochemical Pharmacology · 被引 13)
• Fatty acid-binding proteins in cancers (2025 · International Journal of Surgery · 被引 12)